 Most synovial sarcomas contain a chromosomal translocation t(X;18), which results in the formation of an oncoprotein SS18-SSX critical to the viability of synovial sarcoma.     ///    Exploitation of SS18-SSX and its protein partners will allow us to develop potent tumor-specific therapeutic agents..     ///    "In addition, we have identified a potential mediator of SS18-SSX function in exon 8. "    ///    SS18-SSX represents a tumor-specific target in synovial sarcoma. 